References
- Cooke VA, Fletcher AK. Deep vein thrombosis among injecting drug users in Sheffield. Emerg Med J 2006;23:777–9.
- Cornford CS, Mason JM, Inns F. Deep vein thromboses in users of opioid drugs: incidence, prevalence, and risk factors. Br J Gen Pract 2011;61:e781–6.
- Tovi F, Fliss DM, Noyek AM. Septic internal jugular vein thrombosis. J Otolaryngol 1993;22:415–20.
- Chowdhury K, Bloom J, Black MJ, Al-Noury K. Spontaneous and nonspontaneous internal jugular vein thrombosis. Head Neck 1990;12:168–173.
- Dimitropoulou D, Lagadinou M, Papayiannis T, Siabi V, Gogos CA, Marangos M. Septic thrombophlebitis caused by Fusobacterium necrophorum in an intravenous drug user. Case Rep Infect Dis 2013;2013:870846.
- Ascher E, Salles-Cunha S, Hingorani A. Morbidity and mortality associated with internal jugular vein thromboses. Vasc Endovascular Surg 2005;39:335–9.
- Major KM, Bulic S, Rowe VL, Patel K, Weaver FA. Internal jugular, subclavian, and axillary deep venous thrombosis and the risk of pulmonary embolism. Vascular 2008;16:73–9.
- McColl MD, Tait RC, Greer IA, Walker ID. Injecting drug use is a risk factor for deep vein thrombosis in women in Glasgow. Br J Haematol 2001;112:641–3.
- Fäh F, Zimmerli W, Jordi M, Schoenenberger RA. Septic deep venous thrombosis in intravenous drug users. Swiss Med Wkly 2002;132:386–92.
- Karkos PD, Asrani S, Karkos CD, Leong SC, Theochari EG, Alexopoulou TD, et al. Lemierre’s syndrome: a systematic review. Laryngoscope 2009;119:1552–9.
- Takahashi TA, Merrill JO, Boyko EJ, Bradley KA. Type and location of injection drug use-related soft tissue infections predict hospitalization. J Urban Health 2003;80:127–36.
- Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infect Dis Clin North Am 2002;16:697–712.
- Giyanani VL, Mirfakhraee M, Gerlock AJ Jr, Meyers PC. Computed tomography of internal jugular vein thrombosis. J Comput Tomogr 1985;9:33–7.
- Kim BY, Yoon DY, Kim HC, Kim ES, Baek S, Lim KJ, et al. Thrombophlebitis of the internal jugular vein (Lemierre syndrome): clinical and CT findings. Acta Radiol 2013; 54:622–7.
- Lin D, Reeck JB, Murr AH. Internal jugular vein thrombosis and deep neck infection from intravenous drug use: management strategy. Laryngoscope 2004;114: 56–60.
- Mertz D, Viktorin N, Wolbers M, Laifer G, Leimenstoll B, Fluckiger U, et al. Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis. BMC Infect Dis 2008;8:42.
- Mertz D, Khanlari B, Viktorin N, Battegay M, Fluckiger U. Less than 28 days of intravenous antibiotic treatment is sufficient for suppurative thrombophlebitis in injection drug users. Clin Infect Dis 2008;46:741–4.
- Bick RL. Proficient and cost-effective approaches for the prevention and treatment of venous thrombosis and thromboembolism. Drugs 2000;60:575–95.
- Mackenzie AR, Laing RB, Douglas JG, Greaves M, Smith CC. High prevalence of iliofemoral venous thrombosis with severe groin infection among injecting drug users in North East Scotland: successful use of low molecular weight heparin with antibiotics. Postgrad Med J 2000;76:561–5.
- Valiukiene L, Naudziūnas A, Unikauskas A. Treatment and prophylaxis of deep venous thrombosis with low molecular weight heparins (meta-analysis of clinical trials). Medicina (Kaunas) 2003;39:352–8.